--- title: "Pre-market hot trades in US stocks: Gulf Resources fell 7.10% in pre-market trading, with financial concerns and financing dilution hitting the stock price hard" type: "News" locale: "en" url: "https://longbridge.com/en/news/281756094.md" description: "Gulf Resources pre-market down 7.10%; Profusa pre-market up 133.51%; Focus Media pre-market up 89.82%; iRobot pre-market up 53.94%" datetime: "2026-04-06T11:52:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281756094.md) - [en](https://longbridge.com/en/news/281756094.md) - [zh-HK](https://longbridge.com/zh-HK/news/281756094.md) --- # Pre-market hot trades in US stocks: Gulf Resources fell 7.10% in pre-market trading, with financial concerns and financing dilution hitting the stock price hard **Pre-market Hot Trades in US Stocks** Gulf Resources fell 7.10% in pre-market trading. Based on recent news, 1. On April 2, Gulf Resources announced its latest financial status and operational conditions through the EDGAR system. This announcement raised market concerns about the company's financial health, leading to a decline in stock price. 2. On April 3, Gulf Resources announced the completion of private financing to raise capital. Although the financing aids the company's future development, it diluted the interests of existing shareholders in the short term, putting pressure on the stock price. 3. On April 3, Gulf Resources announced a partnership with Kore.ai to develop enterprise-level artificial intelligence solutions. Despite the long-term potential of this collaboration, the market remains cautious about its short-term actual benefits, failing to boost the stock price. Concerns about the company's financial health have intensified. **Top Gainers in Pre-market US Stocks** Profusa rose 133.51% in pre-market trading. Based on recent key news: 1. On April 6, Profusa announced the signing of a letter of intent to acquire BioInsights' PanOmics molecular diagnostics platform, with a transaction amount of approximately $30 million in an all-stock deal. This move grants Profusa exclusive rights to the technology and allows for the validation of new diagnostic tests using clinical samples, significantly boosting the stock price. Source: Reuters 2. On April 6, Profusa plans to collaborate with Mayo Clinic to utilize the PanOmics platform to monitor pre- and post-operative conditions of pancreatic cancer patients, further expanding its influence in the precision diagnostics market. This collaboration is seen as a significant advancement for the company in pancreatic cancer research, enhancing market confidence. Source: Reuters 3. On April 6, Profusa amended its financing agreement to issue $555,555.55 of 12% senior secured convertible notes to increase working capital and support business operations. This move is viewed as an important step for the company to raise funds for expanding its diagnostic business. Source: SEC announcement on precision diagnostics market expansion, significant capital inflow. Focus Media rose 89.82% in pre-market trading. Based on recent news: 1. On April 3, Focus Media released its latest financial report, showing that the company's revenue and profit in the last quarter exceeded market expectations. This news boosted investor confidence, leading to a significant rise in stock price. 2. On April 2, Focus Media announced a strategic cooperation agreement with a large technology company, which is expected to significantly enhance the company's market competitiveness and profitability. This news further stimulated the rise in stock price. 3. On April 1, analysts generally upgraded their ratings for Focus Media, believing that the company has enormous growth potential in the future. This optimistic market expectation also contributed to the rise in stock price. The overall strong performance of the technology sector recently has led to optimistic market sentiment. iRobot rose 53.94% in pre-market trading, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation ### Related Stocks - [GURE.US](https://longbridge.com/en/quote/GURE.US.md) ## Related News & Research - [Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer | SLXN Stock News](https://longbridge.com/en/news/286425411.md) - [Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News](https://longbridge.com/en/news/286772951.md) - [AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer | AIM Stock News](https://longbridge.com/en/news/286419549.md) - [Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade | PPCB Stock News](https://longbridge.com/en/news/287069272.md) - [Alpha Tau Q1 Net Loss Expands; Plans Enrollment Completion In IMPACT Study In Q3,2026; Stock Up](https://longbridge.com/en/news/286879279.md)